Performance of idarucizumab as antidote of dabigatran in daily clinical practice

SJ van der Wall; N van Rein; B van den Bemt; Marieke Kruip; K Meijer; LCJ te Boome; TA Simmers; AM Alings; R Tieleman; PE Westerweel; F Klok; M Huisman

doi:10.1093/europace/euy220

Performance of idarucizumab as antidote of dabigatran in daily clinical practice

SJ van der Wall, N van Rein, B van den Bemt, Marieke Kruip, K Meijer, LCJ te Boome, TA Simmers, AM Alings, R Tieleman, PE Westerweel, F Klok, M Huisman

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	414-420
Number of pages	7
Journal	Europace
Volume	21
Issue number	3
DOIs	https://doi.org/10.1093/europace/euy220
Publication status	Published - 2019

Research programs

EMC COEUR-09

Access to Document

10.1093/europace/euy220

http://hdl.handle.net/1765/118208

Cite this

@article{066fb048359846e8bdd33963f9f79d15,

title = "Performance of idarucizumab as antidote of dabigatran in daily clinical practice",

author = "{van der Wall}, SJ and {van Rein}, N and {van den Bemt}, B and Marieke Kruip and K Meijer and {te Boome}, LCJ and TA Simmers and AM Alings and R Tieleman and PE Westerweel and F Klok and M Huisman",

year = "2019",

doi = "10.1093/europace/euy220",

language = "Undefined/Unknown",

volume = "21",

pages = "414--420",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Performance of idarucizumab as antidote of dabigatran in daily clinical practice

AU - van der Wall, SJ

AU - van Rein, N

AU - van den Bemt, B

AU - Kruip, Marieke

AU - Meijer, K

AU - te Boome, LCJ

AU - Simmers, TA

AU - Alings, AM

AU - Tieleman, R

AU - Westerweel, PE

AU - Klok, F

AU - Huisman, M

PY - 2019

Y1 - 2019

U2 - 10.1093/europace/euy220

DO - 10.1093/europace/euy220

M3 - Article

C2 - 30339226

SN - 1099-5129

VL - 21

SP - 414

EP - 420

JO - Europace

JF - Europace

IS - 3

ER -